JPMorgan analyst Jessica Fye reiterated an Overweight rating and $330.00 price target on Alnylam Pharmaceuticals (NASDAQ: ALNY)The analyst comments: "With ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE